A case of toxic epidermal necrolysis probably due to etoricoxib
This case report describes a rare incidence of etoricoxib-induced toxic epidermal necrolysis (TEN) in a 25-year-old woman. The patient presented with rapidly evolving rashes, initially over the face and upper body but subsequently involving the total body surface area. There was an extensive ulcerat...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Journal of Current Research in Scientific Medicine |
Subjects: | |
Online Access: | http://www.jcrsmed.org/article.asp?issn=2455-3069;year=2019;volume=5;issue=2;spage=118;epage=121;aulast=Thakur |
id |
doaj-8ce3595d2eb742afba28ef30de9bb87b |
---|---|
record_format |
Article |
spelling |
doaj-8ce3595d2eb742afba28ef30de9bb87b2020-11-25T02:36:53ZengWolters Kluwer Medknow PublicationsJournal of Current Research in Scientific Medicine2455-30692455-30692019-01-015211812110.4103/jcrsm.jcrsm_22_19A case of toxic epidermal necrolysis probably due to etoricoxibSayanta ThakurSandeep LahiryThis case report describes a rare incidence of etoricoxib-induced toxic epidermal necrolysis (TEN) in a 25-year-old woman. The patient presented with rapidly evolving rashes, initially over the face and upper body but subsequently involving the total body surface area. There was an extensive ulceration of buccal mucosa along with eyelid edema, crusting, and corneal ulceration. Naranjo's and WHO–UMC score for this adverse event was “seven;” hence, causality was “probable.” SCORTEN (severity-of-illness score) was “one” with a predicted mortality of 3.2%. Due to persistent hypotension and risk of impending sepsis, aggressive fluid resuscitation and antibiotics were initiated. Cyclosporine and systemic steroids were added later, following which the patient had a prompt recovery. She was discharged after 28 days of hospitalization. However, etoricoxib-induced TEN is a rare clinical association, with very few previously reported cases.http://www.jcrsmed.org/article.asp?issn=2455-3069;year=2019;volume=5;issue=2;spage=118;epage=121;aulast=Thakuradverse drug reactionetoricoxibtoxic epidermal necrolysis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sayanta Thakur Sandeep Lahiry |
spellingShingle |
Sayanta Thakur Sandeep Lahiry A case of toxic epidermal necrolysis probably due to etoricoxib Journal of Current Research in Scientific Medicine adverse drug reaction etoricoxib toxic epidermal necrolysis |
author_facet |
Sayanta Thakur Sandeep Lahiry |
author_sort |
Sayanta Thakur |
title |
A case of toxic epidermal necrolysis probably due to etoricoxib |
title_short |
A case of toxic epidermal necrolysis probably due to etoricoxib |
title_full |
A case of toxic epidermal necrolysis probably due to etoricoxib |
title_fullStr |
A case of toxic epidermal necrolysis probably due to etoricoxib |
title_full_unstemmed |
A case of toxic epidermal necrolysis probably due to etoricoxib |
title_sort |
case of toxic epidermal necrolysis probably due to etoricoxib |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Current Research in Scientific Medicine |
issn |
2455-3069 2455-3069 |
publishDate |
2019-01-01 |
description |
This case report describes a rare incidence of etoricoxib-induced toxic epidermal necrolysis (TEN) in a 25-year-old woman. The patient presented with rapidly evolving rashes, initially over the face and upper body but subsequently involving the total body surface area. There was an extensive ulceration of buccal mucosa along with eyelid edema, crusting, and corneal ulceration. Naranjo's and WHO–UMC score for this adverse event was “seven;” hence, causality was “probable.” SCORTEN (severity-of-illness score) was “one” with a predicted mortality of 3.2%. Due to persistent hypotension and risk of impending sepsis, aggressive fluid resuscitation and antibiotics were initiated. Cyclosporine and systemic steroids were added later, following which the patient had a prompt recovery. She was discharged after 28 days of hospitalization. However, etoricoxib-induced TEN is a rare clinical association, with very few previously reported cases. |
topic |
adverse drug reaction etoricoxib toxic epidermal necrolysis |
url |
http://www.jcrsmed.org/article.asp?issn=2455-3069;year=2019;volume=5;issue=2;spage=118;epage=121;aulast=Thakur |
work_keys_str_mv |
AT sayantathakur acaseoftoxicepidermalnecrolysisprobablyduetoetoricoxib AT sandeeplahiry acaseoftoxicepidermalnecrolysisprobablyduetoetoricoxib AT sayantathakur caseoftoxicepidermalnecrolysisprobablyduetoetoricoxib AT sandeeplahiry caseoftoxicepidermalnecrolysisprobablyduetoetoricoxib |
_version_ |
1724798193161469952 |